Login to Your Account



Shows 100 Percent Protection

SIGA Skyrockets On SIGA-246 Animal Data Against Smallpox

By Jennifer Boggs


Thursday, October 19, 2006
Shares of SIGA Technologies Inc. jumped 130 percent on news that its smallpox drug, SIGA-246, demonstrated 100 percent protection against the human smallpox virus in a primate trial. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription